Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures

2001/02/01 by Sean C. Semple, Sandra K. Klimuk, Troy O. Harasym +8 · 28 citations
Biochemistry, Genetics and Molecular Biology · #RNA Interference and Gene Delivery #Advanced biosensing and bioanalysis techniques #DNA and Nucleic Acid Chemistry

paper · doi:10.1016/s0005-2736(00)00343-6

Cited by

• Lipids and Lipid Derivatives for RNA Delivery
• Decoding pH‐Driven Phase Transition of Lipid Nanoparticles
• mRNA vaccines for infectious diseases: principles, delivery and clinical translation
• Progress towards in vivo use of siRNAs. [europepmc]
• A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. [europepmc]
• Lipidic systems for in vivo siRNA delivery. [europepmc]
• Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. [europepmc]
• Pulmonary delivery of therapeutic siRNA. [europepmc]
• Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. [europepmc]
• Advances in Lipid Nanoparticles for siRNA Delivery. [europepmc]
• Delivery of oligonucleotides with lipid nanoparticles. [europepmc]
• Lipid nanoparticles for delivery of messenger RNA to the back of the eye. [europepmc]
• Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors. [europepmc]
• Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation. [europepmc]
• Recent advances in siRNA delivery mediated by lipid-based nanoparticles. [europepmc]
• Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics. [europepmc]
• Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. [europepmc]
• Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles. [europepmc]
• Delivery of oligonucleotide-based therapeutics: challenges and opportunities. [europepmc]
• From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. [europepmc]
• Lipids and Lipid Derivatives for RNA Delivery. [europepmc]
• Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. [europepmc]
• Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles. [europepmc]
• Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. [europepmc]
• mRNA vaccines for infectious diseases: principles, delivery and clinical translation. [europepmc]
• Recent Advances in Lipid Nanoparticles for Delivery of mRNA. [europepmc]
• Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics. [europepmc]
• Smart nanoparticles for cancer therapy. [europepmc]